Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Sep 15;7(5):889-904.
doi: 10.3945/an.116.012138. Print 2016 Sep.

Mediterranean Diet, Cognitive Function, and Dementia: A Systematic Review of the Evidence

Affiliations

Mediterranean Diet, Cognitive Function, and Dementia: A Systematic Review of the Evidence

Sara Danuta Petersson et al. Adv Nutr. .

Abstract

A growing body of evidence suggests that adherence to the Mediterranean diet (MD) may protect against cognitive decline and dementia. Many epidemiologic studies and several randomized controlled trials (RCTs) have found positive effects of the MD on cognitive function, but findings remain inconsistent. The aim of this systematic review was to provide an update on the current knowledge of the effects of the MD on cognitive function, cognitive impairment, Alzheimer disease (AD), and all-type dementia. Five databases were searched-PubMed, Embase, CINAHL, CENTRAL, and PsycINFO (1806 to 25 May 2015)-with the use of prespecified criteria. Human studies that were published in English without any restriction on study type, population assessed, intervention period, follow-up time, or publication date, and that examined the association between adherence to the MD and cognitive function or dementia symptoms (as measured by cognitive function tests), were included. Only primary publication types were included. Thirty-two studies from 25 unique cohorts, including 5 RCTs and 27 observational studies, met the inclusion criteria. The majority of studies showed that the MD was associated with improved cognitive function, a decreased risk of cognitive impairment or decreased risk of dementia, or AD. Three studies found no correlation between the MD and AD, 3 further studies found no association between the MD and cognitive impairment, and 5 studies found no association between the MD and cognitive function. There was large heterogeneity, and studies differed with regard to quality. Based on the findings and the limitations in study design, we conclude that adherence to the MD is associated with better cognitive performance. However, it should be noted that the majority of findings come from epidemiologic studies that provide evidence for a correlation between the MD and cognition but not for a cause-and-effect relation. More controlled trials are required to establish a causational relation.

Keywords: Alzheimer disease; Mediterranean diet; cognitive function; cognitive impairment; dementia; dietary patterns; systematic review.

PubMed Disclaimer

Conflict of interest statement

2 Author disclosures: SD Petersson and E Philippou, no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Flowchart of the study selection process.

References

    1. Daviglus ML, Bell CC, Berrettini W, Bowen PE, Connolly ES, Cox NJ, Dunbar-Jacob JM, Granieri EC, Hunt G, McGarry K, et al. . National Institutes of Health state-of-the-science conference statement: preventing Alzheimer disease and cognitive decline. Ann Intern Med 2010;153:176–81. - PubMed
    1. Alzheimer’s SocietyAlzheimer’s Society online information—About dementia—What is dementia? Leading the fight against Dementia [Internet]. 2014 [cited 2016 Mar 30]. Available from: http://www.alzheimers.org.uk/site/scripts/documents.php?categoryID=200360.
    1. Tricco AC, Soobiah C, Berliner S, Ho JM, Ng CH, Ashoor HM, Chen MH, Hemmelgarn BSS. Efficacy and safety of cognitive enhancers for patients with mild cognitive impairment: a systematic review and meta-analysis. CMAJ 2013;185:1393–401. - PMC - PubMed
    1. Tan CC, Yu JT, Wang HF, Tan MS, Meng XF, Wang C, Jiang T, Zhu XC, Tan L. Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer’s disease: a systematic review and meta-analysis. J Alzheimers Dis 2014;41:615–31. - PubMed
    1. Srisuwan P. Primary prevention of dementia: focus on modifiable risk factors. J Med Assoc Thai 2013;96:251–8. - PubMed

Publication types